Single-domain antibodies, or nanobodies, have recently been thrust into the spotlight as a potential treatment for COVID-19. In fact, a COVID-19 nanobody-based treatment developed is currently in preclinical testing. Even though nanobodies are only beginning to realize their therapeutic potential, they have been studied for decades.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed